Explore the vast range of titles available.

Intentional doping is the core of semiconductor technologies to tune electrical and optical properties of semiconductors for electronic devices, however, it has shown to be a grand challenge for halide perovskites. Here, we show that some metal ions, such as silver, strontium, cerium ions, which exist in the precursors of halide perovskites as impurities, can n-dope the surface of perovskites from being intrinsic to metallic. The low solubility of these ions in halide perovskite crystals excludes the metal impurities to perovskite surfaces, leaving the interior of perovskite crystals intrinsic. Computation shows these metal ions introduce many electronic states close to the conduction band minimum of perovskites and induce n-doping, which is in striking contrast to passivating ions such as potassium and rubidium ion. The discovery of metallic surface doping of perovskites enables new device and material designs that combine the intrinsic interior and heavily doped surface of perovskites. Intentional doping is important in semiconductors in order to tune the material property, yet the mechanism in metal halide perovskite is not well-understood. Here, the authors use silver, strontium, and cerium ions to showcase n-type doping on perovskite surface even up to metallic state.

The efficiencies of all-perovskite tandem devices are improving quickly. However, their complex interconnection layer (ICL) structures—with typically four or more layers deposited by different processes—limit their prospects for applications. Here, we report an ICL in all-perovskite tandem cells consisting merely of a fullerene layer and a SnO 2– x (0 <  x  < 1) layer. The C 60 layer is unintentionally n-doped by iodine ions from the perovskite and thus acts as an effective electron collecting layer. The SnO 2– x layer, formed by the incomplete oxidization of tin ( x  = 1.76), has ambipolar carrier transport property enabled by the presence of a large density of Sn 2+ . The C 60 /SnO 1.76 ICL forms Ohmic contacts with both wide and narrow bandgap perovskite subcells with low contact resistivity. The ICL boosts the efficiencies of small-area tandem cells (5.9 mm 2 ) and large-area tandem cells (1.15 cm 2 ) to 24.4% and 22.2%, respectively. The tandem cells remain 94% of its initial efficiency after continues 1-sun illumination for 1,000 h. Interconnecting layers are critical to the efficiency of tandem solar cells and a high number of layers is typically needed to ensure good electrical properties. Yu et. al show that a fullerene/tin-oxide interconnecting layer enables 24.4% efficiency and improved stability in all-perovskite tandem solar cells.

The ionic defects at the surfaces and grain boundaries of organic–inorganic halide perovskite films are detrimental to both the efficiency and stability of perovskite solar cells. Here, we show that quaternary ammonium halides can effectively passivate ionic defects in several different types of hybrid perovskite with their negative- and positive-charged components. The efficient defect passivation reduces the charge trap density and elongates the carrier recombination lifetime, which is supported by density-function-theory calculation. The defect passivation reduces the open-circuit-voltage deficit of the p–i–n-structured device to 0.39 V, and boosts the efficiency to a certified value of 20.59 ± 0.45%. Moreover, the defect healing also significantly enhances the stability of films in ambient conditions. Our findings provide an avenue for defect passivation to further improve both the efficiency and stability of solar cells. Losses in solar cells can be caused by material defects in the bulk or at interfaces. Here, Zheng et al.  use quaternary ammonium halides to passivate various perovskite absorbers and prepare solar cells with certified efficiency above 20%, suggesting that both anionic and cation defects are affected.

Identifying the origin of intrinsic instability for organic–inorganic halide perovskites (OIHPs) is crucial for their application in electronic devices, including solar cells, photodetectors, radiation detectors, and light-emitting diodes, as their efficiencies or sensitivities have already been demonstrated to be competitive with commercial available devices. Here we show that free charges in OIHPs, whether generated by incident light or by current-injection from electrodes, can reduce their stability, while efficient charge extraction effectively stabilizes the perovskite materials. The excess of both holes and electrons reduce the activation energy for ion migration within OIHPs, accelerating the degradation of OIHPs, while the excess holes and electrons facilitate the migration of cations or anions, respectively. OIHP solar cells capable of efficient charge-carrier extraction show improved light stability under regular operation conditions compared to an open-circuit condition where the photo-generated charges are confined in the perovskite layers. Optoelectronic devices based on organic–inorganic halide perovskites show promising performance, but their poor stability impedes the commercialization. Here Lin et al. show that excess free charges are detrimental and efficient charge-carrier extraction is necessary for improved device stability.

Structural defects in conjugated copolymers are severely detrimental to the optoelectronic properties and the performance of the resulting electronic devices fabricated from them. Therefore, the much-desired precision synthesis of conjugated copolymers with highly regular repeat units is important, but presents a significant challenge to synthetic materials chemists. To this end, aryl sulfides are naturally abundant substances and offer unrealized potential in cross-coupling reactions. Here we report an efficient room temperature polycondensation protocol which implements aryl disulfide C-S activation to produce defect-minimized semiconducting conjugated copolymers with broad scope and applicability. Thus, a broad series of arylstannanes and thioethers are employed via the present protocol to afford copolymers with number-average molecular weights ( M n s) of 10.0–45.0 kDa. MALDI and NMR analysis of selected copolymers reveals minimal structural defects. Moreover, the polymer trap density here is smaller and the field effect mobility higher than that in the analogous polymer synthesized through thermal-activation Stille coupling. Structural defects in conjugated copolymers are severely detrimental to the optoelectronic properties. Here the authors show an efficient room temperature polycondensation protocol which implements aryl disulfide C-S activation to produce defect-minimized semiconducting conjugated copolymers.

The past three years have witnessed the power conversion efficiency (PCE) of organic solar cells (OSCs) rocketing to over 18%, due to outstanding advantages of non‐fullerene acceptors (NFAs). However, large exciton binding energy (E b) caused by strong Coulombic force is still one of the main limiting factors for high‐performance OSCs. Thus, it is critical to reduce the E b for further enhancement of device performance. Many strategies have been developed to reduce the E b of organic materials previously. In this perspective, the calculation methods for E b and the relationship between E b and voltage loss (V loss) are discussed. Then, the effects of the properties of small‐molecule acceptors on E b from the perspectives of fused‐ring donor cores, end groups, side chains, and molecular packing are discussed. Finally, the potential directions for reducing E b and pointing out the trade‐off between E b and bandgaps/miscibility are put forward. It is hoped that this perspective could provide a new thinking of a molecular design for the breakthrough of OSCs. The large exciton binding energy (E b) is one of the main limiting factors for high‐performance optoelectronic devices. In this perspective, from the point of view of non‐fullerene acceptors, it is summarized that extending the electron donating core, increasing the dipole moment on the end groups, and introducing highly polarizable side chains reduces E b.

This review used traditional and network meta-analyses (NMA) to conduct a comprehensive study of antithrombotic therapies in children with thromboembolic disease. We searched the PubMed, Embase, Cochrane Library, Web of Science and ClinicalTrials.gov databases from their inception to 26 February, 2023. And we finally included 16 randomized controlled trials. In the prevention of thromboembolic events (TEs), the use of anticoagulants had a low risk of TEs (relative risk (RR) 0.73, 95% CI 0.56 to 0.94) and a high risk of minor bleeding (RR 1.43, 95% CI 1.09 to 1.86) compared with no anticoagulants. In the treatment of TEs, direct oral anticoagulants (DOACs) were not inferior to standard anticoagulation in terms of efficacy and safety outcomes. In NMA, rivaroxaban and apixaban showed the lowest risk for TEs and major or clinically relevant nonmajor bleeding. According to the overall assessment of efficacy and safety, dabigatran may be the best choice for children with thromboembolic disease. The results of our study will provide references and suggestions for clinical drug selection.

For the process of photovoltaic conversion in organic solar cells (OSCs) and quantum‐dot solar cells (QDSCs), three of four steps are determined by exciton behavior, namely, exciton generation, exciton diffusion, and exciton dissociation. Therefore, it is of great importance to regulate exciton behavior in OSCs and QDSCs for achieving high power conversion efficiency. Due to the rapid development in materials and device fabrication, great progress has been made to manage the exciton behavior to achieve prolonged exciton diffusion length and improved exciton dissociation in recent years. In this review, we first introduce the parameters that affect exciton behavior, followed by the methods to measure exciton diffusion length. Then, we provide an overview of the recent advances with regard to exciton behavior investigation in OSCs and QDSCs, including exciton lifetime, exciton diffusion coefficient, and exciton dissociation. Finally, we propose future directions in deepening the understanding of exciton behavior and boosting the performance of OSCs and QDSCs. Exciton behavior plays a crucial role in the photovoltaic conversion process of organic solar cells (OSCs) and quantum‐dot solar cells (QDSCs). Great progress has been made to regulate the exciton behavior in recent years. Herein, we summarize the advancement in exciton behavior studies of OSCs and QDSCs from the exciton diffusion coefficient, exciton lifetime, and exciton dissociation.

Background Due to its predictable pharmacodynamics and pharmacokinetics, stable blood concentration, and relatively short half-life, rivaroxaban is widely used in the prevention and treatment of thrombosis. It nevertheless exhibits a certain level of inter-individual variability, and its safety concerns, including bleeding, are also becoming more noteworthy. Case presentation This paper describes an elderly patient with nonvalvular atrial fibrillation that was complicated with coronary heart disease, who is a homozygous mutation carrier of the ABCB1 allele ( rs 1045642 C > T, rs 1128503 C > T, rs 2032582 G > T). He was developed severe gastrointestinal bleeding during administration of oral rivaroxaban combined with aspirin. We investigated the possible causes of the bleeding, and any potential correlation with the ABCB1 gene polymorphism, combined with antiplatelet drugs and anemia. Conclusion In the treatment of patients with atrial fibrillation, doctors should pay close attention to drug interactions with antiplatelet agents in high-risk groups and closely monitor various examination indexes, including hemoglobin. In this case, bleeding might be potentially influenced by homozygous mutations in ABCB1 , but more clinical data are needed to clarify the association between ABCB1 polymorphism and rivaroxaban pharmacokinetics and bleeding.

Although there are certain drug categories associated with heart failure (HF), most of the associated risks are unclear. We investigated the top drugs associated with HF and acute HF (AHF) reported in the FDA Adverse Event Reporting System (FAERS). We reviewed publicly available FAERS databases from 2004 to 2023. Using the search terms \"cardiac failure\" or \"cardiac failure acute\" and classifying cases by drug name, we processed and analyzed drug reports related to HF or AHF. From 2004 to 2023, 17,379,609 adverse drug events were reported by FAERS, of which 240,050 (1.38%) were reported as HF. Among those with HF, the male-to-female ratio was 0.94% and 52.37% were >65 years old; 46.2% were from the United States. There were 5,971 patients with AHF. We identified 38 drugs and 13 drug classes with a potential high risk of causing HF, and 41 drugs and 19 drug classes were associated with AHF. The median onset times of HF and AHF were 83 days (IQR: 11-416) and 49 days (IQR: 8-259), respectively. The Weibull shape parameter (WSP) test showed early failure-type profile characteristics. This study highlights key drugs associated with drug-induced HF and AHF, emphasizing the importance of early risk assessment and close monitoring, particularly during the initial stages of treatment. These findings contribute to a better understanding of drug-induced HF and provide a basis for future research on its underlying mechanisms.